0000899243-20-019087.txt : 20200714
0000899243-20-019087.hdr.sgml : 20200714
20200714170036
ACCESSION NUMBER: 0000899243-20-019087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200622
FILED AS OF DATE: 20200714
DATE AS OF CHANGE: 20200714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Naschitz Anat
CENTRAL INDEX KEY: 0001792060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 201027591
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 4155004614
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-22
0
0001785173
89bio, Inc.
ETNB
0001792060
Naschitz Anat
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
1
0
1
0
Stock Option (Right to Buy)
24.29
2020-06-22
4
A
0
7000
0.00
A
2030-06-22
Common Stock
7000
7000
I
See footnote
This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, which will vest in full on June 22, 2021, subject to the Reporting Person's continued service to the Issuer through such date.
These securities are held of record by Anat Naschitz ("Naschitz"), an employee of OrbiMed Advisors Israel II Limited ("Israel II Limited"). Pursuant to an agreement between Israel II Limited, OrbiMed Israel GP II, L.P. ("Israel II GP"), OrbiMed Advisors LLC ("OrbiMed Advisors"), and OrbiMed Capital GP VI LLC ("GP VI"), Naschitz is obligated to transfer these securities, or the economic benefit thereof, to Israel II Limited, Israel II GP, OrbiMed Advisors, and GP VI, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP and OrbiMed Israel Partners II, L.P.
/s/ Ryan A. Murr, as attorney-in-fact for Anat Naschitz
2020-07-14